It was noted in our laboratory that certain strains of Haemophilus influenzae yielded zone sizes interpreted as resistant to the ampicillin (AMP) disk on chocolate-Mueller-Hinton agar (CMH) but showed no evidence of 13-lactamase (13-Lac) activity. Although it is known that a second mechanism of AMP resistance exists, strains with this mechanism are uncommon. To investigate this apparent discrepancy, a study of 100 consecutive clinical isolates of H. influenzae collected over a 6-month period was performed. 
Haemophilus influenzae is now recognized as an important cause of acute otitis media, maxillary sinusitis, and childhood meningitis as well as many other pathologic conditions (4) . The increase in resistance of H. infiuenzae to ampicillin (AMP) and other antimicrobial agents necessitates a reliable method for susceptibility testing of this organism. Although rapid tests for 1-lactamase (,B-Lac) are available, reliable growth-based susceptibility tests are necessary to detect resistance to AMP by alternative mechanisms and resistance to other antimicrobial agents. The fastidious nature of H. infiuenzae necessitates the use of complex growth media, which requires the use of blood products. The opacity of media such as chocolate-Mueller-Hinton agar (CMH) often makes interpretation difficult (7) . A new medium called Haemophilus test medium (HTM), consisting of Mueller-Hinton agar supplemented with yeast extract, hematin (X factor), and NAD (V factor) (11), supports the growth of H. influenzae and has the advantage of clarity, permitting easier measurement of zone diameters. This medium is recommended by the National Committee for Clinical Laboratory Standards (NCCLS) (standards M2-A4) for disk susceptibility testing of H. influenzae.
This study was undertaken to investigate the frequent isolation in our laboratory of H. infuenzae strains that were * Corresponding author. resistant on CMH but were ,B-Lac negative. AMP resistance in H. influenzae is most often due to the plasmid-mediated production of TEM 3-Lac; however, AMP-resistant non-rLac-producing strains of H. influenzae have been reported. Possible alternative mechanisms of AMP resistance include altered penicillin-binding proteins and diminished permeation of beta-lactam antimicrobial agents through the cell wall outer membrane (5, 12) . Isolates with this mechanism are considered rare (6, 18 (BBL and Remel, Lenexa, Kans.) were streaked according to procedures described in the NCCLS standards M2-A3-S2 and M2-A4, respectively, (13, 14) . All disks were the BBL Sensi-disk brand, manufactured by Becton Dickinson Microbiology Systems. H. influenzae ATCC 49247 was included with each batch of tests.
(ii) MICs. MICs were determined by using dried commercially prepared microdilution panels (Sensititre Microbiology Systems, Westlake, Ohio) and NCCLS standard M7-A2 (15) . After the organisms were suspended in Mueller-Hinton broth as described above, 50 ,ul of each suspension was inoculated into 10 ml of HTM broth (BBL and Remel).
Each well of the Sensititre panel was inoculated with 100 ,ul of each suspension by using an autoinoculator (Sensititre). Antimicrobial concentration ranges for AMP, chloramphenicol, cefotaxime, ciprofloxacin, and AMP-sulbactam (SAM) were 1 to 64, 0.5 to 64, 0.5 to 64, 0.5 to 4, and 1/0.5 to 32/16, respectively. Plates were incubated at 35°C for 20 to 24 h. MICs were determined according to standard practice relative to the final concentration of antibiotic in each well.
(iii) Enzyme studies. P-Lac production was determined by using nitrocefin-impregnated paper disks (2). Positive and negative control strains were tested along with patient isolates. (15) .
The distribution of these zone diameters is shown in Fig. 2 (14) . Table 1 compares zone size interpretive criteria for CMH and HTM with corresponding MICs.
Between the early 1970s, when 3-Lac-mediated resistance was recognized, and the late 1980s, the prevalence of AMPresistant H. influenzae has continued to increase. Most laboratories reported that less than 5% of their isolates produced P-Lac prior to 1978. The incidence in Great Britain in 1981 had increased to 14% (16) .
The prevalence of ,B-Lac-mediated AMP resistance in this study (17%) with 0% AMP resistance due to other mechanisms parallels the findings of Doern et al. (6) , who in 1988 reported an overall rate of 20% for P-Lac-producing strains of H. influenzae. They also reported that high-level AMP resistance among H. influenzae strains lacking the TEMtype 1-Lac was extremely uncommon in the United States.
Since the prevalence of 3-Lac-producing strains of H. influenzae has increased so dramatically, the use of empiric therapy with AMP alone for serious H. influenzae infections is not advisable.
AMP MICs were <64 Fxg/ml for only three isolates among the 17 3-Lac-producing strains. For 16 of these isolates (one ,B-Lac-producing isolate failed to grow), all zone sizes as well as MICs fell within the resistant range (13) (14) (15) 
